Systematic (IUPAC) name | |
---|---|
(3R,4R,5E,10E,12E,14S,26R,26aS)-26-[[2-(diethylamino)ethyl]sulfonyl]-8,9,14,15,24,25,26,26a- octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]-dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a603007 |
Pregnancy cat. | ? |
Legal status | ? |
Pharmacokinetic data | |
Half-life | 1 hour |
Identifiers | |
CAS number | 112362-50-2 |
ATC code | None |
PubChem | CID 6435782 |
DrugBank | DB01764 |
ChemSpider | 4940480 |
UNII | R9M4FJE48E |
KEGG | D00853 |
ChEMBL | CHEMBL1200937 |
Chemical data | |
Formula | C34H50N4O9S |
Mol. mass | 690.85 g/mol |
(verify) |
(what is this?)
Dalfopristin is a streptogramin antibiotic derived from pristinamycin IIA. The combination quinupristin/dalfopristin, in a weight-to-weight ratio of 30% quinupristin to 70% dalfopristin, is used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium.[1]